Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812... Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others. Show more
ROCKVILLE, Md., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.17 | -0.467161308052 | 36.39 | 36.53 | 34.86 | 251674 | 35.64007829 | CS |
| 4 | 2.42 | 7.15976331361 | 33.8 | 39.37 | 33.43 | 417946 | 35.690149 | CS |
| 12 | 1.11 | 3.16149245229 | 35.11 | 39.37 | 29.5 | 366873 | 33.62856401 | CS |
| 26 | 8.22 | 29.3571428571 | 28 | 39.37 | 25.53 | 470025 | 30.55907996 | CS |
| 52 | 8.69 | 31.5655648384 | 27.53 | 39.37 | 25.53 | 434078 | 30.22187121 | CS |
| 156 | 2.65 | 7.89395293417 | 33.57 | 42.09 | 21.99 | 427547 | 31.46871678 | CS |
| 260 | 14.31 | 65.3126426289 | 21.91 | 42.09 | 13.12 | 465689 | 28.38034226 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
